TEPMETKO® (tepotinib) Receives Positive CHMP Opinion for Patients with Advanced NSCLC with METex14 Skipping ...

ROCKLAND, Mass.--(BUSINESS WIRE)--Dec 17, 2021--. EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European"...